UBS strategists see a potential year-end rally in US equities, driven by a combination of seasonal trends, strong investor sentiment, and the possibility of reduced market volatility. The investment ...
Swiss money manager cuts mid-2025 and end-2025 targets for MSCI China Index because of tariff uncertainties and disappointing ...
UBS analyst Trung Huynh maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $31.00. The ...
Ibotta (NYSE:IBTA) stock tumbled 20% in premarket trade, as UBS downgraded the company to Neutral citing lack of growth ...
We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...
We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...
The review concerns Russian customers at Credit Suisse that UBS is now in charge of after rescuing the lender, two of the ...
PB Fintech's new initiatives will help it achieve EBITDA break-even by FY27, and a steady renewals pool should support ...
Fintel reports that on November 13, 2024, UBS upgraded their outlook for 3M (NYSE:MMM) from Neutral to Buy. Analyst Price ...
We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors.